Critical Care Diagnostics Market Report

Critical Care Diagnostics Market Analysis By Test Type (Routine & Special Chemistry, Flow Cytometry, Hematology, Immunoproteins, Microbial and Infectious Diseases, Coagulation Testing), By End-use type (Operation Rooms, Emergency Rooms, Intensive Care Units), By Region (U.S., Canada, Germany, UK, China, India, Brazil, Mexico, South Africa) And Segment Forecasts To 2024

  • Report ID: GVR-1-68038-010-1
  • Number of Pages: 85
  • Format: Electronic (PDF)

Table of Content

查pter 1 Methodology and Scope
1.1. Research methodology
1.2. Research scope & assumption
1.3. List of data sources
查pter 2 Executive Summary
查pter 3 Market Snapshot
查pter 4 Market Variables, Trends & Scope
4.1. Market segmentation
4.2. Market size and growth prospects, 2013 - 2024
4.3. Critical care diagnostics: Market dynamics
4.3.1. Market Driver Analysis
4.3.1.1. Growing patient demand for rapid diagnosis and treatment
4.3.1.2. Increasing geriatric population
4.3.1.3. Telehealth and remote communications between diagnostics and laboratories
4.3.2. Market Restraint Analysis
4.3.2.1. Increased cost of diagnostics tools and dearth of skilled labor
4.4. Penetration & growth prospect mapping
4.5. Critical Care Diagnostics Company - SWOT analysis, by factor (political &legal, economic and technological)
4.6. Industry Analysis - Porter's
查pter 5. Market Categorization 1: Type Estimates & Trend Analysis
5.1. Critical care diagnostics market: Type movement analysis
5.1.1. Routine and special chemistry
5.1.1.1. Routine and special chemistry market estimates and forecasts, 2013 - 2024 (USD Million)
5.1.2. Flow cytometry
5.1.2.1. Flow cytometry market estimates and forecasts, 2013 - 2024 (USD Million)
5.1.3. Hematology
5.1.3.1. Hematology market estimates and forecasts, 2013 - 2024 (USD Million)
5.1.4. Microbial and infectious test
5.1.4.1.微生物和传染性esti测试市场mates and forecasts, 2013 - 2024 (USD Million)
5.1.5. Coagulation
5.1.5.1. Coagulation market estimates and forecasts, 2013 - 2024 (USD Million)
5.1.6. Others
5.1.6.1. Other market estimates and forecasts, 2013 - 2024 (USD Million)
查pter 6. Market Categorization 2: End-User Estimates & Trend Analysis
6.1. Critical care diagnostics market: End-user movement analysis
6.1.1. Operating rooms
6.1.1.1. Operating rooms market estimates and forecasts, 2013 - 2024 (USD Million)
6.1.2. Emergency rooms
6.1.2.1. Emergency rooms market estimates and forecasts, 2013 - 2024 (USD Million)
6.1.3. Intensive care units
6.1.3.1. Intensive care units market estimates and forecasts, 2013 - 2024 (USD Million)
6.1.4. Others
6.1.4.1. Other market estimates and forecasts, 2013 - 2024 (USD Million)
查pter 7. Market Categorization 3: Regional Estimates & Trend Analysis, by Type & End-User
7.1. Critical care diagnostics market share by region, 2016 & 2024
7.1.1.北美
7.1.1.1. U.S. market estimates and forecasts, by type, 2013 - 2024 (USD Million)
7.1.1.2. U.S. market estimates and forecasts, by end-user, 2013 - 2024 (USD Million)
7.1.1.3. Canada market estimates and forecasts, by type, 2013 - 2024 (USD Million)
7.1.1.4. Canada market estimates and forecasts, by end-user, 2013 - 2024 (USD Million)
7.1.2. Europe
7.1.2.1. Germany market estimates and forecasts by type, 2013 - 2024 (USD Million)
7.1.2.2. Germany market estimates and forecasts, by end-user, 2013 - 2024 (USD Million)
7.1.2.3. UK market estimates and forecasts, by type, 2013 - 2024 (USD Million)
7.1.2.4. UK market estimates and forecasts, by end-user, 2013 - 2024 (USD Million)
7.1.3. Asia Pacific
7.1.3.1. China market estimates and forecasts, by type, 2013 - 2024 (USD Million)
7.1.3.2. China market estimates and forecasts, by end-user, 2013 - 2024 (USD Million)
7.1.3.3. India market estimates and forecasts, by type, 2013 - 2024 (USD Million)
7.1.3.4. India market estimates and forecasts, by end-user, 2013 - 2024 (USD Million)
7.1.4. Latin America
7.1.4.1. Mexico estimates and forecasts, by type, 2013 - 2024 (USD Million)
7.1.4.2. Mexico estimates and forecasts, by end-user, 2013 - 2024 (USD Million)
7.1.4.3. Brazil estimates and forecasts, by type, 2013 - 2024 (USD Million)
7.1.4.4.巴西东部时间imates and forecasts, by end-user, 2013 - 2024 (USD Million)
7.1.5. MEA
7.1.5.1. South Africa estimates and forecasts, by type, 2013 - 2024 (USD Million)
7.1.5.2. South Africa estimates and forecasts, by end-user,2013 - 2024 (USD Million)
7.1.5.3. Saudi Arabia estimates and forecasts, by type, 2013 - 2024 (USD Million)
7.1.5.4. Saudi Arabia estimates and forecasts, by end-user, 2013 - 2024 (USD Million)
查pter 8. Competitive Landscape
8.1. Strategy framework
8.2. Market participation categorization
8.3. Company Profiles
8.3.1. Abbott
8.3.1.1. Company Overview
8.3.1.2. Financial Performance
8.3.1.3. Product Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. Alere, Inc.
8.3.2.1. Company Overview
8.3.2.2. Financial Performance
8.3.2.3. Product Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. Beckman-Coulter/ Danaher
8.3.3.1. Company Overview
8.3.3.2. Financial Performance
8.3.3.3. Product Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. Roche Diagnostics Ltd.
8.3.4.1. Company Overview
8.3.4.2. Financial Performance
8.3.4.3. Product Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. Becton Dickinson & Co.
8.3.5.1. Company Overview
8.3.5.2. Financial Performance
8.3.5.3. Product Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. EKF Diagnostics
8.3.6.1. Company Overview
8.3.6.2. Financial Performance
8.3.6.3. Product Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. BioMerieux, Inc.
8.3.7.1. Company Overview
8.3.7.2. Financial Performance
8.3.7.3. Product Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. Siemens Healthcare Diagnostics
8.3.8.1.公司概述
8.3.8.2. Financial Performance
8.3.8.3. Product Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. Chembio Diagnostic Systems, Inc.
8.3.9.1. Company Overview
8.3.9.2. Financial Performance
8.3.9.3. Product Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. Bayer Healthcare AG
8.3.10.1. Company Overview
8.3.10.2. Financial Performance
8.3.10.3.产品基准测试
8.3.10.4. Strategic Initiatives


List of Tables

1. North America critical care diagnostics market revenue, by test type, 2013 - 2024 (USD Million)
2. North America critical care diagnostics market revenue, by end-user application, 2013 - 2024 (USD Million)
3. U.S. critical care diagnostics market revenue, by test type, 2013 - 2024 (USD Million)
4. U.S. critical care diagnostics market revenue, by end-user application, 2016 - 2024 (USD Million)
5. Canada critical care diagnostics market revenue, by test type, 2016 - 2024 (USD Million)
6. Canada critical care diagnostics market revenue, by end-user application, 2016 - 2024 (USD Million)
7. Europe critical care diagnostics market revenue, by test type, 2016 - 2024 (USD Million)
8. Europe critical care diagnostics market revenue, by end-user application, 2016 - 2024 (USD Million)
9. Germany critical care diagnostics market revenue, by test type, 2016 - 2024 (USD Million)
10. Germany critical care diagnostics market revenue, by end-user application, 2016 - 2024 (USD Million)
11. UK critical care diagnostics market revenue, by test type, 2013 - 2024 (USD Million)
12. UK critical care diagnostics market revenue, by end-user application, 2013 - 2024 (USD Million)
13. Asia Pacific critical care diagnostics market revenue, by test type, 2013 - 2024 (USD Million)
14. Asia Pacific critical care diagnostics market revenue, by end-user application, 2013 - 2024 (USD Million)
15. China critical care diagnostics market revenue, by test type, 2013 - 2024 (USD Million)
16. China critical care diagnostics market revenue, by end-user application, 2013 - 2024 (USD Million)
17. India critical care diagnostics market revenue, by test type, 2013 - 2024 (USD Million)
18. India critical care diagnostics market revenue, by end-user application, 2013 - 2024 (USD Million)
19. Latin America critical care diagnostics market revenue, by test type, 2013 - 2024 (USD Million)
20. Latin America critical care diagnostics market revenue, by end-user application, 2013 - 2024 (USD Million)
21. Brazil critical care diagnostics market revenue, by test type, 2013 - 2024 (USD Million)
22. Brazil critical care diagnostics market revenue, by end-user application, 2013 - 2024 (USD Million)
23. Mexico critical care diagnostics market revenue, by test type, 2013 - 2024 (USD Million)
24. Mexico critical care diagnostics market revenue, by end-user application, 2013 - 2024 (USD Million)
25. MEA critical care diagnostics market revenue, by test type, 2013 - 2024 (USD Million)
26. MEA critical care diagnostics market revenue, by end-user application, 2013 - 2024 (USD Million)
27. South Africa critical care diagnostics market revenue, by test type, 2013 - 2024 (USD Million)
28. South Africa critical care diagnostics market revenue, by end-user application, 2013 - 2024 (USD Million)
29. Saudi Arabia critical care diagnostics market revenue, by test type, 2013 - 2024 (USD Million)
30. Saudi Arabia critical care diagnostics market revenue, by end-user application, 2013 - 2024 (USD Million)


List of Figures

1. Market summary
2. Market trends & outlook
3 Market segmentation & scope
4. Market driver relevance analysis (Current & future impact)
5. Penetration & growth prospect mapping
6. SWOT Analysis, By Factor (political & legal, economic and technological)
7. Porter’s Five Forces Analysis
8. Critical care diagnostics market type outlook key takeaways
9. Critical care diagnostics market: Type movement analysis
10. Critical care diagnostics market end user outlook key takeaways
11. Critical care diagnostics market: End-user movement analysis
12. Critical care diagnostics market, 2013 - 2024 (USD Millions)
13. Regional market place: Key takeaways
14. Regional outlook, 2016 & 2024
15. Strategy framework
16. Participant categorization

What questions do you have? Get quick response from our industry experts.Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

NEED A CUSTOM REPORT?

We can customize every report -free of charge- including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us nowto get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read ourprivacy policy.

great place to work icon